Compare ADMA Biologics Inc (ADMA) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? ADMA Biologics Inc trades at $9.22 (market cap $2.13B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $23.18. The key difference: ProShares UltraShort Bloomberg Natural Gas ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | KOLD | |
|---|---|---|
Market Cap | $2.13B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $20.38 | $49.39 |
52-Week Low | $7.60 | $13.58 |
Enterprise Value | $2.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
KOLD trades at $23.29, down 0.64% on the day, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The stock faces support at $23 and resistance at $24. Recent natural gas market volatility, driven by weather patterns and LNG demand fluctuations, creates trading opportunities for this bearish natural gas ETF.
As a tactical trading instrument, KOLD offers exposure to inverse natural gas price movements amid heightened energy market volatility. Key risks include weather-driven demand shifts and geopolitical factors affecting gas prices, while the bullish technical setup suggests potential near-term upside for this specialized energy sector play.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
